Diet Therapy in the Management of Inflammatory Bowel Diseases (IBD) and Irritable Bowel Syndrome (IBS): Evaluation of the Low-FODMAP Diet for Treatment
DOI:
https://doi.org/10.33448/rsd-v14i6.49077Keywords:
Diet therapy, Diet, FODMAPs, Carbohydrate, Inflammatory bowel diseases, Irritable bowel syndrome.Abstract
Inflammatory Bowel Diseases (IBD), including Crohn’s disease, ulcerative colitis, and syndromes such as Irritable Bowel Syndrome (IBS), are chronic conditions characterized by recurrent inflammation of the gastrointestinal tract (GI). This study aims to analyze the use of a low-FODMAP diet as diet therapy in the management of inflammatory bowel diseases, evaluating its impact on symptom reduction, patients’ quality of life, and modulation of the inflammatory response. This is a literature review analyzing published studies that focus on evidence regarding the application of the diet in the treatment of IBD and gastrointestinal syndromes. According to the literature, treatment with a low-FODMAP diet has a significant impact on the manifestation and severity of symptoms in most patients. In this context, diet therapy—which involves strategies aimed at adjusting food intake to reduce intestinal inflammation and relieve symptoms—has become an increasingly valued approach. It is concluded that the low-FODMAP diet is an effective dietary strategy in the management of Inflammatory Bowel Diseases (IBD) and Irritable Bowel Syndrome (IBS), promoting significant improvement in gastrointestinal symptoms as well as in patients’ quality of life. Scientific literature points to notable benefits in modulating the inflammatory response and reducing associated discomforts such as abdominal pain, bloating, flatulence, and diarrhea. Although more controlled clinical studies are still needed to standardize the application of this nutritional approach, the available data support its use as a valuable complementary tool in the treatment of these chronic conditions.
References
Catapani, W. R. & (2004). Conceitos atuais em síndrome do intestino irritável. nepas.emnuvens.com.brWR CatapaniArquivos Médicos do ABC. 29(1). https://nepas.emnuvens.com.br/amabc/article/view/314.
Burgos, F N; Salviano, G M S & Belo, FM (2008). Doenças inflamatórias intestinais: o que há de novo em terapianutricional? Rev. bras. nutr. Clín. https://pesquisa.bvsalud.org/portal/resource/pt/lil-559346.
Cavalcante, R. M. S., Moura, M. S. B. de, Braz, D. C., & Nogueira, N. do N. (2020). Retocolite ulcerativa e citocinas: uma revisão da literatura. Research, Society and Development. 9 (9), e314997145. https://doi.org/10.33448/RSD-V9I9.7145.
Cotrim, M. A., Alexandre, L., Marzano, S., Pedro, J., Batista, T., Lopes, M., Lira, C., & Leal Fraga, C. (2020). O papel da microbiota intestinal na patogênese das doenças inflamatórias intestinais The role of the intestinal microbiota in the pathogenesis of inflammatory. ojs.brazilianjournals.com.br. 3, 4558–65. https://doi.org/10.34119/BJHR.V3.N3-052.
De Souza, M. M. H., Barbosa, D. A., Espinosa, M. M., & Belasco, A. G. S. (2011). Qualidade de vida de pacientes portadores de doença inflamatória intestinal. Acta Paulista de Enfermagem. 24 (4), 479–84. https://doi.org/10.1590/S0103-21002011000400006.
Dourado, C. S., Siqueira, D. da C., Matos, F. L. S. de, Sousa, J. C. S. de, Silva, P. V. N., Sampaio, R. E. S., Costa, V. A. da, & Mendes, W. G. B. (2022). A associação entre uma alimentação rica em carboidratos e o desenvolvimento de gastroenteropatias: revisão integrativa da literatura. Brazilian Journal of Health Review. 5(2), 4772–90. https://doi.org/10.34119/BJHRV5N2-066.
Farmacêuticas, S. S.-R. B. de C. (2006). Probióticos e prebióticos: o estado da arte. Revista Brasileira de Ciências Farmacêuticas. 42(1). https://doi.org/10.1590/S1516-
Ferreira, G. S., Deus, M. H. A., & Junior, E. A. (2021). Fisiopatologia e etiologias das doenças inflamatórias intestinais: uma revisão sistemática de literatura / Pathophysiology and etiologies of the inflammatory bowel diseases: a systematic review. Brazilian Journal of Health Review. 4(4), 17061–76. https://doi.org/10.34119/BJHRV4N4-210.
Filipa, T., & Bastos, S. (2016). Síndrome do intestino irritável e dieta com restrição de FODMAPs. https://repositorio.ulisboa.pt/handle/10451/29541.
Gibson, P. R., & Shepherd, S. J. (2005). Visão pessoal: alimento para reflexão – estilo de vida ocidental e suscetibilidade à doença de Crohn. A hipótese FODMAP. Farmacologia alimentar e, 21(12), 1399–1409. https://doi.org/10.1111/J.1365-2036.2005.02506.X.
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 146(1). https://doi.org/10.1053/J.GASTRO.2013.09.046.
Hanauer, S. B. (2006). Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflammatory bowel diseases, 12(5 suppl. 1). https://doi.org/10.1097/01.MIB.0000195385.19268.68.
Heringer, P. N., Dias, M. C. B. de M., Tecchio, J. V. S., Melo, M. de F. V. da S., Figueiredo, M. dos S., Cabral, C. G., Costa, R. R. de S., Araújo, C. P. de S., Araújo, C. P. de S., Souza, S. P. M., Castor, M. H. M., & Ramos, F. F. (2023). Novas abordagens nutricionais no manejo das doenças inflamatórias intestinais. Revista Ibero-Americana de Humanidades, Ciências e Educação. 9(9), 119–30. https://doi.org/10.51891/REASE.V9I9.11155.
Hewawasam, S. P., Iacovou, M., Muir, J. G., & Gibson, P. R. (2018). Dietary practices and FODMAPs in South Asia: Applicability of the low FODMAP diet to patients with irritable bowel syndrome. Journal of Gastroenterology and Hepatology (Australia). 33(2), 365–74. https://doi.org/10.1111/JGH.13885.
Khorshidi, M., Djafarian, K., Aghayei, E. & Shab-Bidar, S. (2019). Padrões alimentares a posteriori e risco de doença inflamatória intestinal: uma meta-análise de estudos observacionais. Revista Internacional de Pesquisa em Vitaminas e Nutrição. 90(3–4), 376–84. https://doi.org/10.1024/0300-9831/A000508.
Kiesler, P., Fuss, I. J., & Strober, W. (2015). Experimental Models of Inflammatory Bowel Diseases. Cellular and Molecular Gastroenterology and Hepatology. 1(2), 154. https://doi.org/10.1016/J.JCMGH.2015.01.006.
Kim, D. H., & Cheon, J. H. (2017). Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune network, 17 (1), 25–40. https://doi.org/10.4110/IN.2017.17.1.25. Libertucci, J., Dutta, U., Kaur, S., Jury, J., Rossi, L., Fontes, M. E., Shajib, M. S., Khan, W. I., Surette, M. G., Verdu, E. F., & Armstrong, D. (2018). Diferenças relacionadas à inflamação na microbiota associada à mucosa e na função da barreira intestinal na doença de Crohn colônica. American Journal. 31 (3), G420–G431. https://doi.org/10.1152/AJPGI.00411.2017.
Libertucci, J., Dutta, U., Kaur, S., Jury, J., Rossi, L., Fontes, M. E., Shajib, M. S., Khan, W. I., Surette, M. G., Verdu, E. F., & Armstrong, D. (2018). Diferenças relacionadas à inflamação na microbiota associada à mucosa e na função da barreira intestinal na doença de Crohn colônica. American Journal, 315(3), G420–G431. https://doi.org/10.1152/AJPGI.00411.2017.
Liu, W., Ye, A., Han, F., & Han, J. (2019). Advances and challenges in liposome digestion: Surface interaction, biological fate, and GIT modeling. Advances in colloid and interface science. 263, 52–67. https://doi.org/10.1016/J.CIS.2018.11.007
Cecília Juliani Aurélio, C. J. (2023). Fisiologia Geral Descomplicada. ISBN: 9786556753256. https://www.estantevirtual.com.br/livro/fisiologia-geral-descomplicada-087-6844-000-BK.
Maranhão, D., Vieira, A., med, T. C.-J. bras., & 2015, undefined. ([s.d.]). Características e diagnóstico diferencial das doenças inflamatórias intestinais. J. bras. med. https://pesquisa.bvsalud.org/portal/resource/pt/lil-756137.
Martins, A., Pequito, A., & Baltazar, A. (2020). Disbiose Intestinal e Síndrome do Intestino Irritável: efeito de uma dieta baixa em FODMAPs. Acta Portuguesa de Nutrição. https://doi.org/10.21011/APN.2020.2207.
Matter, R., & Mazo, D. F. D. C. (2010). Intolerância à lactose: mudança de paradigmas com a biologia molecular. Revista da Associação Médica Brasileira. 56 (2), 230–6. https://doi.org/10.1590/S0104-42302010000200025.
Maurício, L., Ribeiro, S., Santos, L., & de Miranda, D. B. (2021). Predictors associated with sickle cell nephropathy: a systematic review. Revista da Associacao Medica Brasileira. 67(2), 313–317. https://doi.org/10.1590/1806-9282.67.02.20200676.
Menesy, A., Hammad, M., Aref, S., & Abozeid, F. (2023). P251 Level of Interleukin-17 in Inflammatory Bowel Disease and Its relation to disease activity. Journal of Crohn’s and Colitis. 17 (Supplement_1), i402–i403. https://doi.org/10.1093/ECCO-JCC/JJAC190.0381.
Patógenos, D. F.-, & 2014, undefined. (2014). Desenvolvimento inicial da microbiota intestinal e saúde imunológica. Patógenos. 3(3), 769–90. https://doi.org/10.3390/PATHOGENS3030769.
Pedersen, N., Ankersen, D. V., Felding, M., Wachmann, H., Végh, Z., Molzen, L., Burisch, J., Andersen, J. R., & Munkholm, P. (2017). Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World Journal of Gastroenterology. 23(18), 3356–66. https://doi.org/10.3748/WJG.V23.I18.3356.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. Núcleo de tecnologia educacional da Universidade Federal de Santa Maria. Rockers, P. C., & Bärnighausen, T. (2013). Interventions for hiring, retaining and training district health systems managers in low- and middle-income countries. The Cochrane database of systematic reviews. 4 (4). https://doi.org/10.1002/14651858.CD009035.PUB2.
Rockers, P. C., & Bärnighausen, T. (2013). Interventions for hiring, retaining and training district health systems managers in low- and middle-income countries. The Cochrane database of systematic reviews, 4(4). https://doi.org/10.1002/14651858.CD009035.pub2.
Satokari, R., Fuentes, S., Mattila, E., Jalanka, J., De Vos, W. M., & Arkkila, P. (2014). Fecal transplantation treatment of antibiotic-induced. Case Reports in Medicine. https://doi.org/10.1155/2014/913867.
Silva, M. T., Leite, F. M. M., Santiago, F. V. P., Albuquerque, Í. G. S. de, Brito, A. P. S. O., & Garcia, H. C. R. (2020). Diagnóstico e tratamento da síndrome do intestino irritável: revisão sistemática. Pará Research Medical Journal. 4, 1–8. https://doi.org/10.4322/PRMJ.2019.041.
Simões, C. D., Maganinho, M., & Sousa, A. S. (2022). FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence. European Journal of Nutrition. 61 (3), 1187–98. https://doi.org/10.1007/s00394-021-02755-1.
Staudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012a). Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. Journal of Nutrition. 142 (8), 1510–18. https://doi.org/10.3945/jn.112.159285.
Staudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012b). Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. Journal of Nutrition. 142 (8), 1510–8. https://doi.org/10.3945/JN.112.159285.
Staudacher, H. M., & Whelan, K. (2017). The low FODMAP diet: Recent advances in understanding its mechanisms and efficacy in IBS. Gut. 66 (8), 1517–27. https://doi.org/10.1136/GUTJNL-2017-313750.
Vakil, N. (2018). Dietary Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAPs) and Gastrointestinal Disease. Nutrition in Clinical Practice, 33(4), 468–475. https://doi.org/10.1002/NCP.10108.
Varjú, P., Farkas, N., Hegyi, P., Garami, A., Szabó, I., Illés, A., Solymár, M., Vincze, Á., Balaskó, M., Pár, G., Bajor, J., Szűcs, Á., Huszár, O., Pécsi, D., & Czimmer, J. (2017). Low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet improves symptoms in adults suffering from irritable bowel syndrome (IBS) compared to standard IBS diet: A meta-analysis of clinical studies. PLoS ONE. 12 (8). https://doi.org/10.1371/JOURNAL.PONE.0182942.
Varney, J., Barrett, J., Scarlata, K., Catsos, P., Gibson, P. R., & Muir, J. G. (2017). FODMAPs: food composition, defining cutoff values and international application. Journal of Gastroenterology and Hepatology (Australia), 32, 53–61. https://doi.org/10.1111/JGH.13698.
Vieira, É. A. (2021). Implicações dos FODMAPs nas Doenças Gastrointestinais. https://repositorio-aberto.up.pt/handle/10216/136643.
Yang, L., Liu, C., Zhao, W., He, C., Ding, J., Dai, R., Xu, K., Xiao, L., Luo, L., Liu, S., Li, W., & Meng, H. (2018). Impaired Autophagy in Intestinal Epithelial Cells Alters Gut Microbiota and Host Immune Responses. Applied and Environmental Microbiology. 84 (18), e00880-18. https://doi.org/10.1128/AEM.00880-18.
Zhou, M., He, J., Shen, Y., Zhang, C., Wang, J., & Chen, Y. (2017). New Frontiers in Genetics, Gut Microbiota, and Immunity: A Rosetta Stone for the Pathogenesis of Inflammatory Bowel Disease. BioMed Research International. https://doi.org/10.1155/2017/8201672,
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mariana Guimarães Saraiva; Maria Cláudia da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
